Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
The mRNA vaccines for SARS-CoV-2 have demonstrated efficacy and immunogenicity in the real-world setting. However, most of the research on vaccine immunogenicity has been centered on characterizing the antibody response, with limited exploration into the persistence of spike-specific memory B cells....
Main Authors: | Annalisa Ciabattini, Gabiria Pastore, Simone Lucchesi, Giorgio Montesi, Simone Costagli, Jacopo Polvere, Fabio Fiorino, Elena Pettini, Arianna Lippi, Leonardo Ancillotti, Mario Tumbarello, Massimiliano Fabbiani, Francesca Montagnani, Donata Medaglini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/13/1706 |
Similar Items
-
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
by: Annalisa Ciabattini, et al.
Published: (2021-09-01) -
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
by: Gabiria Pastore, et al.
Published: (2024-12-01) -
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
by: Jacopo Polvere, et al.
Published: (2023-01-01) -
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
by: Elena Pettini, et al.
Published: (2021-03-01) -
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
by: Francesca Panza, et al.
Published: (2023-10-01)